Atrás
Rango del Día
$4.81
$5.00
Rango de 52 Semanas
$3.02
$22.42
Volumen
30,035
Promedio 50D / 200D
$4.71
/
$6.01
Cierre Anterior
$4.94
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -78.5 | 0.4 |
| P/B | 24.9 | 2.9 |
| ROE % | -46.9 | 3.8 |
| Net Margin % | -28.6 | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.1 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
No hay estimaciones futuras disponibles
Puntos Clave
Debt/Equity of 0.08 — conservative balance sheet
Negative free cash flow of -22.20M
Capital efficient — spends only 8.63% of revenue on capex
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)105.40%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-46.94%
ROIC-14.86%
Net Margin-28.59%
Op. Margin-19.22%
Seguridad
Debt / Equity
0.08
Current Ratio1.86
Interest Coverage-7.35
Valoración
P/E Ratio
-78.53
P/B Ratio24.92
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 105.40% | Revenue Growth (3Y) | 168.58% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 42.41M | Net Income (TTM) | -12.13M |
| ROE | -46.94% | ROA | -16.34% |
| Gross Margin | 43.38% | Operating Margin | -19.22% |
| Net Margin | -28.59% | Free Cash Flow (TTM) | -22.20M |
| ROIC | -14.86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.08 | Current Ratio | 1.86 |
| Interest Coverage | -7.35 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -78.53 | P/B Ratio | 24.92 |
| P/S Ratio | 22.45 | PEG Ratio | 2.12 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 952.35M | Enterprise Value | 952.06M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 42.41M | 20.65M | 5.88M | 1.46M | 0.0 |
| Net Income | -12.13M | -19.15M | -20.94M | -5.60M | -1.48M |
| EPS (Diluted) | -0.06 | -0.10 | -0.16 | -1.41 | -0.52 |
| Gross Profit | 18.40M | 8.45M | 713,447.0 | 489,594.0 | -18,787.0 |
| Operating Income | -8.15M | -18.98M | -20.67M | -5.68M | -1.41M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 74.23M | 42.39M | 25.48M | 6.98M | 428,607.0 |
| Total Liabilities | 36.01M | 28.93M | 11.18M | 9.66M | 287,281.0 |
| Shareholders' Equity | 38.22M | 13.46M | 14.30M | -2.68M | 141,326.0 |
| Total Debt | 2.92M | 18.20M | 8.22M | 8.27M | 145,000.0 |
| Cash & Equivalents | 3.21M | 466,500.0 | 7.03M | 217,177.0 | 405,774.0 |
| Current Assets | 48.80M | 27.42M | 18.38M | 4.10M | 408,065.0 |
| Current Liabilities | 26.24M | 21.33M | 9.27M | 7.77M | 287,281.0 |